Levi MM - Search Results

1

Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.

Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N. Robbers LF, et al. Among authors: levi mm. Eur Heart J. 2013 Aug;34(30):2346-53. doi: 10.1093/eurheartj/eht100. Epub 2013 Apr 17. Eur Heart J. 2013. PMID: 23594591

2

Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group.

Chamuleau SA, de Winter RJ, Levi M, Adams R, Büller HR, Prins MH, Lie KI, Peters RJ. Chamuleau SA, et al. Heart. 1998 Jul;80(1):35-9. doi: 10.1136/hrt.80.1.35. Heart. 1998. PMID: 9764056 Free PMC article.

3

Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.

Levi MM, Eerenberg E, Löwenberg E, Kamphuisen PW. Levi MM, et al. Neth J Med. 2010 Feb;68(2):68-76. Neth J Med. 2010. PMID: 20167958 Free article. Review.

4

Anticoagulants. Old and new.

Levi M, Eerenberg ES, Kampuisen PW. Levi M, et al. Hamostaseologie. 2011 Nov;31(4):229-35. doi: 10.5482/ha-1153. Epub 2011 Jun 20. Hamostaseologie. 2011. PMID: 21687916 Review.

5

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.

Levi M, Eerenberg E, Kamphuisen PW. Levi M, et al. J Thromb Haemost. 2011 Sep;9(9):1705-12. doi: 10.1111/j.1538-7836.2011.04432.x. J Thromb Haemost. 2011. PMID: 21729240 Free article. Review.

6

Periprocedural reversal and bridging of anticoagulant treatment.

Levi M, Eerenberg E, Kamphuisen PW. Levi M, et al. Neth J Med. 2011 Jun;69(6):268-73. Neth J Med. 2011. PMID: 21868810 Free article. Review.

7

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Eerenberg ES, et al. Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900088 Clinical Trial.

8

Contra: "Antidotes for novel anticoagulants?"--Do we really need them.

Eerenberg ES, Levi M, Büller HR. Eerenberg ES, et al. Thromb Haemost. 2012 Oct;108(4):623-4. doi: 10.1160/TH12-05-0298. Epub 2012 Aug 23. Thromb Haemost. 2012. PMID: 22918223 No abstract available.

9

The potential therapeutic benefit of targeting ADAMTS13 activity.

Eerenberg ES, Levi M. Eerenberg ES, et al. Semin Thromb Hemost. 2014 Feb;40(1):28-33. doi: 10.1055/s-0033-1363156. Epub 2013 Dec 13. Semin Thromb Hemost. 2014. PMID: 24338607 Review.

10

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists.

Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Büller HR. Eerenberg ES, et al. J Thromb Haemost. 2015 Sep;13(9):1590-6. doi: 10.1111/jth.13051. Epub 2015 Aug 22. J Thromb Haemost. 2015. PMID: 26179293 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters